Literature DB >> 15598928

Prognostic factors in ovarian cancer: how close are we to a complete picture?

R Agarwal, S B Kaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15598928     DOI： 10.1093/annonc/mdi104

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  23 in total

1.  Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.

Authors:  Seijeoung Kim; Therese A Dolecek; Faith G Davis
Journal:  Soc Sci Med       Date:  2010-04-22       Impact factor: 4.634

2.  Mode of Referral of Ovarian Cancer Patients: Does it Alter Treatment and Survival?

Authors:  Anas Barakat; Aemn Ismail; Quentin Davies; Supratik Chattopadhyay
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

3.  Predicting time to ovarian carcinoma recurrence using protein markers.

Authors:  Ji-Yeon Yang; Kosuke Yoshihara; Kenichi Tanaka; Masayuki Hatae; Hideaki Masuzaki; Hiroaki Itamochi; Masashi Takano; Kimio Ushijima; Janos L Tanyi; George Coukos; Yiling Lu; Gordon B Mills; Roel G W Verhaak
Journal:  J Clin Invest       Date:  2013-08-15       Impact factor: 14.808

4.  CLINICAL PROGNOSTIC FACTORS IN PRE- AND POST-MENOPAUSAL WOMEN WITH OVARIAN CARCINOMA.

Authors:  O G Trifanescu; L N Gales; R A Trifanescu; R M Anghel
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

5.  Comorbidity and survival among women with ovarian cancer: evidence from prospective studies.

Authors:  Yi-Sheng Jiao; Ting-Ting Gong; Yong-Lai Wang; Qi-Jun Wu
Journal:  Sci Rep       Date:  2015-06-29       Impact factor: 4.379

6.  Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian Cancer.

Authors:  Juan Zhou; Li-Chao Yang; Zhen-Yu He; Fang-Yan Li; San-Gang Wu; Jia-Yuan Sun
Journal:  J Cancer       Date:  2015-08-08       Impact factor: 4.207

7.  Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.

Authors:  Se Ik Kim; Myong Cheol Lim; Jiwon Lim; Young Joo Won; Sang Soo Seo; Sokbom Kang; Sang Yoon Park
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

8.  Effect of Procyanidin-rich Extract from Natural Cocoa Powder on Cellular Viability, Cell Cycle Progression, and Chemoresistance in Human Epithelial Ovarian Carcinoma Cell Lines.

Authors:  Shruti Taparia; Aparna Khanna
Journal:  Pharmacogn Mag       Date:  2016-05-11       Impact factor: 1.085

9.  Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis.

Authors:  P de Graeff; A P G Crijns; S de Jong; M Boezen; W J Post; E G E de Vries; A G J van der Zee; G H de Bock
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

10.  Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.

Authors:  T D Santos; M P Jammal; T P Silveira; E F C Murta; R S Nomelini
Journal:  Pathologica       Date:  2019-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.